Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03908476 · ClinicalTrials.gov registry record · NA
PROLONG Prospective, Multi-center, Open-label, Post-market Study
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 118
- Enrollment target
NCT03908476 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 118 participants.
The verdict
NCT03908476, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
Study Summary
Spinal cord stimulation (SCS) has been shown to be effective for relieving intractable chronic pain. However, a portion of patients who initially succeed with SCS will eventually lose their therapeutic benefit. Reliable methods have not been identified for restoring neuromodulation benefit to this underserved population, so additional research is required. This study will prospectively observe subjects who utilize Abbott neurostimulation devices after failing to sustain pain relief with their previous SCS system. The effectiveness of Abbott systems in restoring neuromodulation benefit will be evaluated over the course of a two-year follow-up.
Interventions
- DEVICE Burst-capable SCS system
- DEVICE DRG Stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2019-04-16 |
| Est. Completion | 2021-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03908476
The ClinicalTrials.gov registry entry for NCT03908476 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Burst-capable SCS system is the first listed.
NCT03908476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03908476 about?
NCT03908476 is a clinical study titled "PROLONG Prospective, Multi-center, Open-label, Post-market Study". Spinal cord stimulation (SCS) has been shown to be effective for relieving intractable chronic pain. However, a portion of patients who initially succeed with SCS will eventually lose their therapeutic benefit. Reliable methods have not been identified for restoring neuromodulation benefit to this u...
What is the current status of trial NCT03908476?
This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2019-04-16. Estimated completion is 2021-11-15.
What interventions are being tested in trial NCT03908476?
The interventions under investigation include: Burst-capable SCS system (DEVICE), DRG Stimulator (DEVICE).
Who is sponsoring clinical trial NCT03908476?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.